[1] V, Levran O, Proudnikov D, Nielsen DA, Kreek MJ. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci , 2010, 1187(1): 184-207. [2] MD, Burmeister M. New insights into the genetics of addiction. Nat Rev Genet , 2009, 10(4): 225-231. [3] LD, Bobashev G, Morris RJ. Researching a local heroin market as a complex adaptive system. Am J Community Psychol , 2009, 44(3-4): 273-286. [4] FJ. Mechanisms of opioid-induced overdose: experimental approach to clinical concerns. Ann Pharm Fr , 2009, 67(5): 353-359. [5] AI. Addiction is a brain disease, and it matters. Science , 1997, 278(5335): 45-47. [6] DM, Sellers EM. Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. CMAJ , 2001, 164(6): 817-821. [7] JA, Echeverry-Alzate V, Bühler KM. The genetic basis of the endocannabinoid system and drug addiction in humans. J Psychopharmacol , 2012, 26(1): 133-143. [8] S, Griffon N, Bourdel MC, Olie JP, Poirier MF, Krebs MO. Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. Am J Med Genet , 2001, 105(8): 749-752. [9] PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, Uhl GR. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry , 2004, 9(10): 916-931. [10] T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM, Sham PC, Collier DA. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry , 2000, 5(2): 128-130. [11] D, Kroslak T, Sipe JC, Randesi M, Li D, Hamon S, Ho A, Ott J, Kreek MJ. Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1. Pharmacogenomics J , 2010, 10(3): 232-242. [12] M, PastorI, dela Calle C, Barrio-Real L, Laso FJ, González-Sarmiento R. Cannabinoid receptor 1 gene is associated with alcohol dependence. Alcohol Clin Exp Res , 2012, 36(2): 267-271. [13] TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis. Addict Biol , 2013, 18(4): 702-708. [14] LJ, Kranzler HR, Luo XG, Covault J, Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biological Psychiatry , 2007, 62(6): 616- 626. [15] PH, Kalsi G, Prescott CA, Hodgkinson CA, Goldman D, Alexander J, van den Oord EJ, Chen X, Sullivan PF, Patterson DG, Walsh D, Kendler KS, Riley BP. Associations of glutamate decarboxylase genes with initial sensitivity and age-at-onset of alcohol dependence in the Irish Affected Sib Pair Study of Alcohol Dependence. Drug Alcohol Depend , 2009, 101(1-2): 80-87. [16] C, Tucci M, Forza G, Barzon L, Palu G, Ferrara SD. Alcohol dependence and glutamate decarboxylase gene polymorphisms in an Italian male population. Alcohol , 2010, 44(5): 407-413. [17] O, Londono D, O'Hara K, Randesi M, Rotrosen J, Casadonte P, Linzy S, Ott J, Adelson M, Kreek MJ. Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav , 2009, 8(5): 531-540. [18] W, Zhu YS, Li SB. Polymorphisms in the glutamate decarboxylase 1 gene associated with heroin dependence. BiochemBiophys Res Commun , 2012, 422(1): 91-96. [19] BS. BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis. Pharmacogenomics, 2013, 14(16): 2055-2065. [20] C, Lan J, Wang Y, Song M, Gao X, Ran L, Moira S, Wang W. Influence of brain-derived neurotrophic factor genetic polymorphisms on the ages of onset for heroin |